Abstract
Introduction
Alzheimer’s disease (AD) is a progressive brain disorder accompanied with synaptic failures and decline in cognitive and learning processes. Protease-activated receptor 1 (PAR1) is the major thrombin receptor in the brain that is implicated in synaptic plasticity and memory formation. In the current study, we hypothesized that inhibition of PAR1 would theoretically prevent amyloid beta (Aβ) accumulation in the brain and then contribute to reduce risk of AD. The aim of the present study was to evaluate the effect of PAR1 inhibition by using SCH (as an inhibitor of PAR1) on spatial learning, memory, and synaptic plasticity in the CA1 region of the hippocampus in rat model of Alzheimer’s disease.
Methods
For the induction of Alzheimer’s disease, amyloid beta (Aβ) 1–42 was injected in the CA1 region of the hippocampus. The rats were divided into four groups: group I (surgical sham); group II rat mode of Alzheimer’s disease (AD); group III (SCH) (25 μg/kg) intraperitoneally (i.p.), and group IV (AD + SCH). After 14 days of protocol, the rats in group III received SCH and 30 min after injection behavioral and electrophysiological tests were performed. Learning and memory ability was assessed by Morris water maze and novel object recognition tests. Extracellular evoked field excitatory postsynaptic potentials (fEPSP) were recorded in the stratum radiatum of the CA1 area.
Results
Our results showed that AD rats showed impairments in learning and memory, and long-term potentiation (LTP) was not induced in these rats. However, injection of SCH overcame the AD-induced impairment in LTP generation in the CA1 area of the hippocampus and improved learning and memory impairment.
Similar content being viewed by others
References
Ahn H-S, Foster C, Boykow G, Stamford A, Manna M, Graziano M (2000) Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1-methylethyl) phenyl] methyl}-7H-pyrrolo [3, 2-f] quinazoline-1, 3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol 60:1425–1434
Almonte AG, Hamill CE, Chhatwal JP, Wingo TS, Barber JA, Lyuboslavsky PN, Sweatt JD, Ressler KJ, White DA, Traynelis SF (2007) Learning and memory deficits in mice lacking protease activated receptor-1. Neurobiol Learn Mem 88:295–304
Almonte AG, Qadri LH, Sultan FA, Watson JA, Mount DJ, Rumbaugh G, Sweatt JD (2013) Protease-activated receptor-1 modulates hippocampal memory formation and synaptic plasticity. J Neurochem 124:109–122
Arai T, Guo J-P, McGeer PL (2005) Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. J Biol Chem 280:5145–5153
Arai T, Miklossy J, Klegeris A, Guo J-P, McGeer PL (2006) Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J Neuropathol Exp Neurol 65:19–25
Bagheri M, Joghataei M-T, Mohseni S, Roghani M (2011) Genistein ameliorates learning and memory deficits in amyloid β (1–40) rat model of Alzheimer’s disease. Neurobiol Learn Mem 95:270–276
Bengoetxea X, Rodriguez-Perdigon M, Ramirez MJ (2015) Object recognition test for studying cognitive impairments in animal models of Alzheimer’s disease. Front Biosci (Schol Ed) 7:10–29
Berkowitz LE, Harvey RE, Drake E, Thompson SM, Clark BJ (2018) Progressive impairment of directional and spatially precise trajectories by TgF344-Alzheimer’s disease rats in the Morris water task. Sci Rep 8:1–14
Berry A, Tomidokoro Y, Ghiso J, Thornton J (2008) Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-β levels in female rats. Horm Behav 54:143–152
Birukova AA, Birukov KG, Smurova K, Adyshev D, Kaibuchi K, Alieva I, Garcia JG, Verin AD (2004) Novel role of microtubules in thrombin-induced endothelial barrier dysfunction. FASEB J 18:1879–1890
Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31–39
Bogovyk R, Lunko O, Fedoriuk M, Isaev D, Krishtal O, Holmes GL, Isaeva E (2017) Effects of protease-activated receptor 1 inhibition on anxiety and fear following status epilepticus. Epilepsy Behav 67:66–69
Bromley-Brits K, Deng Y, Song W (2011) Morris water maze test for learning and memory deficits in Alzheimer's disease model mice. JoVE (Journal of Visualized Experiments): e2920
Burwell RD, Saddoris MP, Bucci DJ, Wiig KA (2004) Corticohippocampal contributions to spatial and contextual learning. J Neurosci 24:3826–3836
Chen L, Yamada K, Nabeshima T, Sokabe M (2006) α7 nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in β-amyloid infused rats. Neuropharmacology 50:254–268
Choi MS, Kim YE, Lee WJ, Choi JW, Park GH, Kim SD, Jeon SJ, Go HS, Shin SM, Kim W-K (2008) Activation of protease-activated receptor1 mediates induction of matrix metalloproteinase-9 by thrombin in rat primary astrocytes. Brain Res Bull 76:368–375
Chong YH, Jung JM, Choi W, Park CW, Choi KS, Suh Y-H (1994) Bacterial expression, purification of full length and carboxyl terminal fragment of Alzheimer amyloid precursor protein and their proteolytic processing by thrombin. Life Sci 54:1259–1268
Ciallella JR, Figueiredo H, Smith-Swintosky V, McGillis JP (1999) Thrombin induces surface and intracellular secretion of amyloid precursor protein from human endothelial cells. Thromb Haemost 81:630–637
Denninger JK, Smith BM, Kirby ED (2018) Novel object recognition and object location behavioral testing in mice on a budget. JoVE (Journal of Visualized Experiments): e58593
Doyle E, Bruce MT, Breen KC, Smith DC, Anderton B, Regan CM (1990) Intraventricular infusions of antibodies to amyloid-β-protein precursor impair the acquisition of a passive avoidance response in the rat. Neurosci Lett 115:97–102
Drummond E, Wisniewski T (2017) Alzheimer’s disease: experimental models and reality. Acta Neuropathol 133:155–175
Ennaceur A (2010) One-trial object recognition in rats and mice: methodological and theoretical issues. Behav Brain Res 215:244–254
Ennaceur A, Meliani K (1992) A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs. non-spatial working memory. Behav Brain Res 51:83–92
Eskandari-Roozbahani N, Shomali T, Taherianfard M (2019) Neuroprotective effect of Zataria multiflora essential oil on rats with Alzheimer disease: a mechanistic study. Basic Clin Neurosci 10:85
Esmaeilpour K, Sheibani V, Shabani M, Mirnajafi-Zadeh J (2017) Effect of low frequency electrical stimulation on seizure-induced short-and long-term impairments in learning and memory in rats. Physiol Behav 168:112–121
Garcia J (2009) Concepts in microvascular endothelial barrier regulation in health and disease. Microvasc Res 77:1–3
Ghasemi T, Sohanaki H, Keshavarz M, Ghasemi E, Parviz M (2017) Low dose Teucrium polium hydro-alcoholic extract treatment effects on spatial memory and hippocampal neuronal count of rat Aβ25-35 model of Alzheimer’s disease. Arch Neurosci 6(3):90893
Gingrich MB, Junge CE, Lyuboslavsky P, Traynelis SF (2000) Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci 20:4582–4595
Grammas P, Samany PG, Thirumangalakudi L (2006) Thrombin and inflammatory proteins are elevated in Alzheimer’s disease microvessels: implications for disease pathogenesis. J Alzheimers Dis 9:51–58
Granic I, Nyakas C, Luiten PG, Eisel UL, Halmy LG, Gross G, Schoemaker H, Möller A, Nimmrich V (2010) Calpain inhibition prevents amyloid-β-induced neurodegeneration and associated behavioral dysfunction in rats. Neuropharmacology 59:334–342
Guan J-x, Sun S-g, Cao X-b, Chen Z-B, Tong E-t (2004) Effect of thrombin on blood brain barrier permeability and its mechanism. Chin Med J 117:1677–1681
Hamill CE, Caudle WM, Richardson JR, Yuan H, Pennell KD, Greene JG, Miller GW, Traynelis SF (2007) Exacerbation of dopaminergic terminal damage in a mouse model of Parkinson’s disease by the G protein-coupled receptor protease-activated receptor 1. Mol Pharmacol 72:653–664
Hamill CE, Mannaioni G, Lyuboslavsky P, Sastre AA, Traynelis SF (2009) Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function. Exp Neurol 217:136–146
Han K-S, Mannaioni G, Hamill CE, Lee J, Junge CE, Lee CJ, Traynelis SF (2011) Activation of protease activated receptor 1 increases the excitability of the dentate granule neurons of hippocampus. Mol Brain 4:1–12
He F-Q, Qiu B-Y, Zhang X-H, Li T-K, Xie Q, Cui D-J, Huang X-L, Gan H-T (2011) Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer’s disease induced by amyloid-β (1–42). Brain Res 1384:89–96
He Y, Zheng M-M, Ma Y, Han X-J, Ma X-Q, Qu C-Q, Du Y-F (2012) Soluble oligomers and fibrillar species of amyloid β-peptide differentially affect cognitive functions and hippocampal inflammatory response. Biochem Biophys Res Commun 429:125–130
Huang C-F, Li G, Ma R, Sun S-G, Chen J-G (2008) Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo. Neurosci Bull 24:66–72
Igarashi K, Murai H, J-i A (1992) Proteolytic processing of amyloid β protein precursor (APP) by thrombin. Biochem Biophys Res Commun 185:1000–1004
Isaev D, Lushnikova I, Lunko O, Zapukhliak O, Maximyuk O, Romanov A, Skibo G, Tian C, Holmes G, Isaeva E (2015) Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis. Neurobiol Dis 78:68–76
Isaeva E, Hernan A, Isaev D, Holmes GL (2012) Thrombin facilitates seizures through activation of persistent sodium current. Ann Neurol 72:192–198
Kubota T, Matsumoto H, Kirino Y (2016) Ameliorative effect of membrane-associated estrogen receptor G protein coupled receptor 30 activation on object recognition memory in mouse models of Alzheimer’s disease. J Pharmacol Sci 131:219–222
Kunešová G, Hlaváček J, Patočka J, Evangelou A, Zikos C, Benaki D, Paravatou-Petsotas M, Pelecanou M, Livaniou E, Slaninova J (2008) The multiple T-maze in vivo testing of the neuroprotective effect of human in analogues. Peptides 29:1982–1987
Lee CJ, Mannaioni G, Yuan H, Woo DH, Gingrich MB, Traynelis SF (2007) Astrocytic control of synaptic NMDA receptors. J Physiol 581:1057–1081
Li X, Bao X, Wang R (2016) Experimental models of Alzheimer’s disease for deciphering the pathogenesis and therapeutic screening. Int J Mol Med 37:271–283
Li J, Wang C, Zhang JH, Cai J-M, Cao Y-P, Sun X-J (2010) Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer’s disease by reduction of oxidative stress. Brain Res 1328:152–161
Lueptow LM (2017) Novel object recognition test for the investigation of learning and memory in mice. JoVE (Journal of Visualized Experiments): e55718
Maggio N, Shavit E, Chapman J, Segal M (2008) Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults. J Neurosci 28:732–736
Moghaddam AH, Zare M (2018) Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer’s disease. Biomed Pharmacother 97:1096–1101
Morris RG (1981) Spatial localization does not require the presence of local cues. Learn Motiv 12:239–260
Navabi SP, Sarkaki A, Mansouri E, Badavi M, Ghadiri A, Farbood Y (2018) The effects of betulinic acid on neurobehavioral activity, electrophysiology and histological changes in an animal model of the Alzheimer’s disease. Behav Brain Res 337:99–106
NISHINO A, SUZUKI M, OHTANI H, MOTOHASHI O, UMEZAWA K, NAGURA H, YOSHIMOTO T (1993) Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 10:167–179
Paxinos G, Watson C (2006) The rat brain in stereotaxic coordinates: hard cover edition. Elsevier
Pompili E, Nori SL, Geloso MC, Guadagni E, Corvino V, Michetti F, Fumagalli L (2004) Trimethyltin-induced differential expression of PAR subtypes in reactive astrocytes of the rat hippocampus. Mol Brain Res 122:93–98
Rajizadeh MA, Esmaeilpour K, Haghparast E, Ebrahimi MN, Sheibani V (2020) Voluntary exercise modulates learning & memory and synaptic plasticity impairments in sleep deprived female rats. Brain Res 1729:146598
Rajizadeh MA, Esmaeilpour K, Masoumi-Ardakani Y, Bejeshk MA, Shabani M, Nakhaee N, Ranjbar MP, Borzadaran FM, Sheibani V (2018) Voluntary exercise impact on cognitive impairments in sleep-deprived intact female rats. Physiol Behav 188:58–66
Rajizadeh MA, Sheibani V, Bejeshk MA, Mohtashami Borzadaran F, Saghari H, Esmaeilpour K (2019) The effects of high intensity exercise on learning and memory impairments followed by combination of sleep deprivation and demyelination induced by ethidium bromide. Int J Neurosci 129:1166–1178
Rao HV, Thirumangalakudi L, Desmond P, Grammas P (2007) Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons. J Neurochem 101:498–505
Robinson JL, Geser F, Corrada MM, Berlau DJ, Arnold SE, Lee VM-Y, Kawas CH, Trojanowski JQ (2011) Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. Brain 134:3708–3715
Saadati H, Sheibani V, Esmaeili-Mahani S, Hajali V, Mazhari S (2014) Prior regular exercise prevents synaptic plasticity impairment in sleep deprived female rats. Brain Res Bull 108:100–105
Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging 27:1372–1384
Selkoe DJ (2008) Soluble oligomers of the amyloid β-protein: impair synaptic plasticity and behavior synaptic plasticity and the mechanism of Alzheimer’s disease. Springer, pp 89-102
Semenikhina M, Bogovyk R, Fedoriuk M, Nikolaienko O, Al Kury LT, Savotchenko A, Krishtal O, Isaeva E (2019) Inhibition of protease-activated receptor 1 ameliorates behavioral deficits and restores hippocampal synaptic plasticity in a rat model of status epilepticus. Neurosci Lett 692:64–68
Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Parducz A, Penke B, Penke Z (2007) β-Amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer’s disease. Neuroscience 147:28–36
Smirnov A, Trupp A, Henkel A, Bloch E, Reulbach U, Lewczuk P, Riggert J, Kornhuber J, Wiltfang J (2009) Differential processing and secretion of Aβ peptides and sAPPα in human platelets is regulated by thrombin and prostaglandine 2. Neurobiol Aging 30:1552–1562
Smith-Swintosky VL, Zimmer S, Fenton JW, Mattson MP (1995) Opposing actions of thrombin and protease nexin-1 on amyloid β-peptide toxicity and on accumulation of peroxides and calcium in hippocampal neurons. J Neurochem 65:1415–1418
Soh UJ, Dores MR, Chen B, Trejo J (2010) Signal transduction by protease-activated receptors. Br J Pharmacol 160:191–203
Sokolova E, Reiser G (2008) Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases. Thromb Haemost 100:576–581
Srivareerat M, Tran TT, Alzoubi KH, Alkadhi KA (2009) Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in β-amyloid rat model of Alzheimer’s disease. Biol Psychiatry 65:918–926
Srivareerat M, Tran TT, Salim S, Aleisa AM, Alkadhi KA (2011) Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer’s disease. Neurobiol Aging 32:834–844
Stepanichev MY, Zdobnova IM, Zarubenko II, Moiseeva YV, Lazareva NA, Onufriev MV, Gulyaeva NV (2004) Amyloid-β (25–35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol Behav 80:647–655
Striggow F, Riek-Burchardt M, Kiesel A, Schmidt W, Henrich-Noack P, Breder J, Krug M, Reymann KG, Reiser G (2001) Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur J Neurosci 14:595–608
Suo Z, Wu M, Citron BA, Palazzo RE, Festoff BW (2003) Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling. J Biol Chem 278:37681–37689
Traynelis SF, Trejo J (2007) Protease-activated receptor signaling: new roles and regulatory mechanisms. Curr Opin Hematol 14:230–235
Wang ZJ, Han WN, Yang GZ, Yuan L, Liu XJ, Li QS, Qi JS (2014) The neuroprotection of Rattin against amyloid β peptide in spatial memory and synaptic plasticity of rats. Hippocampus 24:44–53
Wang X, Li L, Hölscher C, Pan Y, Chen X, Qi J (2010) Val8-glucagon-like peptide-1 protects against Aβ1–40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats. Neuroscience 170:1239–1248
Yamaguchi Y, Kawashima S (2001) Effects of amyloid-β-(25–35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat. Eur J Pharmacol 412:265–272
Yang J-n, Chen J, Xiao M (2017) A protease-activated receptor 1 antagonist protects against global cerebral ischemia/reperfusion injury after asphyxial cardiac arrest in rabbits. Neural Regen Res 12:242
Yokono Y, Kenji H, Masato N, Yota T (2020) Blockade of PAR-1 signaling attenuates cardiac hypertrophy and fibrosis in renin overexpressing hypertensive mice. J Am Heart Assoc 9:119
Zamani E, Parviz M, Roghani M, Mohseni-moghaddam P (2019) Key mechanisms underlying netrin-1 prevention of impaired spatial and object memory in Aβ1-42 CA1-injected rats. Clin Exp Pharmacol Physiol 46:86–93
Zhu W-J, Yamanaka H, Obata K, Dai Y, Kobayashi K, Kozai T, Tokunaga A, Noguchi K (2005) Expression of mRNA for four subtypes of the proteinase-activated receptor in rat dorsal root ganglia. Brain Res 1041:205–211
Acknowledgments
This study was supported by Kerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zare, D., Rajizadeh, M.A., Maneshian, M. et al. Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer’s diseases. Psychopharmacology 238, 1645–1656 (2021). https://doi.org/10.1007/s00213-021-05798-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-021-05798-8